increased use of spironolactone for heart failure is causing more hospitalizations and deaths
September 2004
The increased use of spironolactone for heart failure is causing more hospitalizations and deaths.
The problem started a few years ago when a large well-respected study showed that spironolactone improved survival in patients with severe heart failure.
This was the Randomized Aldactone Evaluation Study (RALES).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote